Efficacy of 10 μg recombinant hepatitis B vaccine in 128 infants 5 years after primary vaccination series in Haidian district of Beijing

Ji-ye FU,Qi DING,Wei ZHANG,Ju-guang WANG,Min LIU

DOI: https://doi.org/10.13329/j.cnki.zyyjk.2017.0107

2017-01-01

Abstract:[Objective] To assess the efficacy of 10 μg recombinant hepatitis B (HepB) vaccine in 128 infants 5 years after 3-dose primary vaccination series in Haidian district of Beijing.[Methods]A total of 128 children,who were respectively vaccinated 3 doses of 10μg hepatitis B vaccine at 0,1 and 6 months of age,and received the primary vaccination effect investigation at 7-12 months old,were enrolled in the study.Venous blood sample (5 ml) was collected 5 years after primary vaccination,to test the antibody to hepatitis B surface antigen (anti-HBs),hepatitis B surface antigen (HBsAg),and antibody to hepatitis B core antigen (anti-HBc).Chi-squared test and t test was used to compare the positive rate of anti-HBs and geometric mean antibody concentrations (GMCs) among children with different characteristics.A multiple logistic regression model was used to obtain the factors influencing the positive rate of anti-HBs 5 years after primary vaccination.[Results]5 years after primary vaccination with 10 μg recombinant hepatitis B vaccine,there was no positive case of HBsAg,and positive rate of antiHBc was 0.78％.The positive rate of anti-HBs was 75.00％ and GMCs was 27.16 mU/ml,which was lower than that after primary vaccination (positive rate of anti-HBs was 100％ and GMCs was 1 628.17 mU/ml),and the differences were statistically significant (xpaired=30.031,P＜0.01;tpaired =36.077,P＜0.01).The multiple logistic regression model showed that the positive rate of anti-HBs 5 years after primary vaccination was associated with high anti-HBs concentration levels after primary vaccination (OR=9.210,95％CI:3.539～23.972,P＜0.01).[Conclusion] The efficacy of 10 μg recombinant HepB vaccine in newborns 5 years after primary vaccination series is satisfactory.Though the positive rate and GMCs of anti-HBs have declined over time,they still remain at high levels.